Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 15,551	$ (153,316)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	8,222	8,090
Amortization of deferred debt issuance costs	3,012	1,916
Amortization	27,777	26,065
Stock-based compensation	12,148	10,218
Deferred income taxes	(607)	70,402
Non-cash adjustment to fair value of contingent consideration liability	3,799	0
Loss on early extinguishment of debt	0	3,426
Loss on convertible notes conversion premium	0	103,125
Loss on convertible notes hedge transactions	0	5,460
Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable	(35,184)	(17,779)
Inventories	4,468	(35,549)
Accounts payable	4,453	13,724
Accrued compensation and benefits	(253)	(12,260)
Other assets	(11,907)	(11,388)
Other liabilities	(8,653)	6,936
Net cash provided by operating activities	22,826	19,070
Cash flows from investing activities:
Purchases of property, plant and equipment	(8,783)	(9,398)
Payments related to business acquisition, net of cash acquired	0	(142,555)
Other	(1,000)	0
Net cash used in investing activities	(9,783)	(151,953)
Cash flows from financing activities:
Payments on term loan	0	(92,981)
Payments on revolving line of credit	(347,000)	(312,000)
Proceeds from revolving line of credit	331,000	172,000
Payments to redeem convertible notes	0	(275,000)
Proceeds from issuance of convertible notes	0	800,000
Payments related to debt issuance costs	0	(21,187)
Dividends paid on common stock	(12,208)	(11,773)
Purchases of convertible notes hedge transactions	0	(187,600)
Proceeds from issuance of warrants	0	72,000
Proceeds from settlement of convertible notes hedge transactions	0	86,228
Payment for settlement of warrants	0	(69,534)
Other, net	13,771	6,457
Net cash provided by (used in) financing activities	(14,437)	166,610
Effect of exchange rate changes on cash and cash equivalents	300	(1,422)
Net increase (decrease) in cash and cash equivalents	(1,094)	32,305
Cash and cash equivalents at beginning of period	28,942	20,847
Cash and cash equivalents at end of period	27,848	53,152
Non-cash investing and financing activities:
Contingent consideration	0	69,402
Dividends payable	$ 6,145	$ 6,092